Status:
COMPLETED
Assessment of Two Methods for Progesterone Dosage During IVF
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Infertility
Eligibility:
FEMALE
18-43 years
Phase:
NA
Brief Summary
Nowadays, 1/7 couple consult because of infertility and some of them will need in vitro fertilization +/- intracytoplasmic sperm injection (IVF+/- ICSI). The IVF process includes a 14 days stimulation...
Eligibility Criteria
Inclusion
- Adult patients between 18 and under 43 years old
- in the course of IVF more or less ICSI of the PMA service of the HFME with transfer of fresh embryo
- Signature of an express consent
- Understanding the French language, both oral and written.
- Affiliated to a social security scheme
Exclusion
- Persons deprived of their liberty by a judicial or administrative decision
- Persons subject to psychiatric care
- Persons admitted to a health or social establishment for purposes other than research
- Participants in another study that could impact the results of the present study, in particular those related to the level of progesterone.
- Adults subject to a legal protection measure (guardianship, curatorship)
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05987657
Start Date
November 15 2023
End Date
November 9 2024
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Femme Mère Enfant
Bron, Rhône, France, 69500